CB8025-21845: A Phase 2, Randomized, Double Blind, Placebo Controlled, Multiple CenterStudy To Evaluate The Safety, Tolerability, And Efficacy Of Seladelpar AdministeredFor 24 Weeks In Adult Subjects With Primary Sclerosing Cholangitis

Project: Research project

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Medicine & Life Sciences